BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
23.12
-2.13 (-8.44%)
Sep 23, 2026, 10:58 AM EDT - Market open
BlossomHill Therapeutics Market Cap
BlossomHill Therapeutics has a market cap or net worth of $708.48 million as of September 23, 2026.
Market Cap
708.48M
Enterprise Value
636.48M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.12
ChartMarket Cap Chart
Since the IPO on August 7, 2026, BlossomHill Therapeutics's market cap has increased from $465.30M to $708.48M, an increase of 52.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 708.48M | -8.44% |
| Sep 22, 2026 | 773.75M | -5.78% |
| Sep 21, 2026 | 821.25M | 4.12% |
| Sep 18, 2026 | 788.77M | -4.03% |
| Sep 17, 2026 | 821.86M | 2.17% |
| Sep 16, 2026 | 804.40M | 18.40% |
| Sep 15, 2026 | 679.37M | 1.98% |
| Sep 14, 2026 | 666.19M | 4.22% |
| Sep 11, 2026 | 639.23M | -3.02% |
| Sep 10, 2026 | 659.15M | -2.23% |
| Sep 9, 2026 | 674.16M | -4.06% |
| Sep 8, 2026 | 702.66M | 4.18% |
| Sep 4, 2026 | 674.47M | 9.94% |
| Sep 3, 2026 | 613.49M | 3.30% |
| Sep 2, 2026 | 593.87M | 2.05% |
| Sep 1, 2026 | 581.92M | 3.77% |
| Aug 31, 2026 | 560.78M | -6.44% |
| Aug 28, 2026 | 599.39M | -1.21% |
| Aug 27, 2026 | 606.74M | 7.26% |
| Aug 26, 2026 | 565.68M | 0.22% |
| Aug 25, 2026 | 564.46M | 14.91% |
| Aug 24, 2026 | 491.22M | -2.14% |
| Aug 21, 2026 | 501.94M | 3.67% |
| Aug 20, 2026 | 484.17M | -2.29% |
| Aug 19, 2026 | 495.51M | 0.43% |
| Aug 18, 2026 | 493.36M | -1.71% |
| Aug 17, 2026 | 501.94M | 1.24% |
| Aug 14, 2026 | 495.81M | -1.04% |
| Aug 13, 2026 | 501.02M | 0.68% |
| Aug 12, 2026 | 497.65M | -1.69% |
| Aug 11, 2026 | 506.23M | 3.31% |
| Aug 10, 2026 | 489.99M | 5.31% |
| Aug 7, 2026 | 465.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 828.70M |
| Design Therapeutics | 823.57M |
| Climb Bio | 816.17M |
| Gyre Therapeutics | 794.19M |
| Annexon | 792.44M |
| Pharming Group | 781.08M |
| Verastem | 758.02M |
| Nuvectis Pharma | 749.38M |